K. Burk

Randomized phase II trial of first-line treatment with sorafenib versus interferon in patients with advanced renal cell carcinoma: Final results

Cezary Szczylik, Tomasz Demkow, Michael Staehler et al. · Journal of Clinical Oncology · 2007 · 138 citations

Urology, Part 1, Phase Ii Trial +15

Phase II study of MTX-HSA in combination with Cisplatin as first line treatment in patients with advanced or metastatic transitional cell carcinoma

Claus Bolling, T. Graefe, C. Lübbing et al. · Investigational New Drugs · 2006 · 77 citations

Urology, Medicine, Phase Ii Study +6

Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion

R. Thödtmann, Andreas Hüttmann, W.E. Berdel et al. · Investigational New Drugs · 1998 · 33 citations

Medicine, Intravenous Short Infusion, Clinical Pharmacology +5

Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans

K. Mross, U. Mayer, K. Hamm et al. · European Journal of Clinical Pharmacology · 1990 · 27 citations

Medicine, Pharmacotherapy, Pharmacokinetics +1

Pharmacokinetics and pharmacodynamics of the new podophyllotoxin derivative NK 611 A study by the AIO groups PHASE-I and APOH

K. Mross, Andreas Hüttmann, Kenneth D. Herbst et al. · Cancer Chemotherapy and Pharmacology · 1996 · 20 citations

Pharmaceutical Science, Biochemistry, Medicine +5